News

Mayo Clinic Seminar on Wearables and Digital Biomarkers in Neuroscience

Our CEO Pierre-Alexandre Fournier was invited by Mayo Clinic to give a seminar on medical wearables and digital biomarkers this week. Thanks again to Dr Jonathon J. Parker, MD PhD, Teryn Johnson, Ph.D., and Bobby Mohan from the Neurosurgery department for organizing the event!

We had the chance to share details about many Hexoskin projects , including our collaboration with Centre de recherche du CHUM (CRCHUM) on epilepsy research, and R&D on respiratory and rare diseases.

We also discussed the importance of running the right trials to validate the digital biomarkers that make medical wearables valuable in different care settings, e.g. before, during, and after hospitalizations. Convincing data from these trials are essential to get through regulatory, reimbursement, and adoption challenges.

Hexoskin @ HITLAB New York City Health Innovation Week

This week Hexoskin was participating in HITLAB's New York City Health Innovation Week in Manhattan. The event was attended by dozens of startups and large life science companies such as Merck, Novo Nordisk, and Sanofi.

To learn more about Hexoskin's involvement in pharma trials and clinical research, please write us at: contact@hexoskin.com

We're Hiring!

Sales Manager, Montréal, Québec, Canada

Do you have a passion for sales and revolutionizing healthcare? Hexoskin is searching for a Sales Manager in Montreal to join our mission of creating cutting-edge digital health and AI solutions.

Apply now to join our team!

Hexoskin at the American Telemedicine Association Nexus 2024 Conference in Phoenix

The American Telemedicine Association has invited Hexoskin's CEO Pierre-Alexandre Fournier to present at the ATA Nexus 2024 conference this May 5th in Phoenix, Arizona.

Mr. Fournier will talk about today’s use cases for medical wearables in telemedicine, with examples from over 10 years of experience in working with patients and professionals, answering clinical questions using data from wearables and mobile devices.

The Hexoskin OneView platform is used by health professionals involved in deploying health programs and decentralized trials at scale with wearables and patient reported outcomes.

This code gives you a $350 discount on the registration fee: ATA24SPKNET

Webinar: Exploring Hexoskin's Latest Features for Researchers & Professionals

Join Us for a New Webinar!

The Hexoskin platform has revolutionized health data collection, empowering professionals and researchers with unprecedented insights.

Join our exclusive webinar on March 13th at 12:00 pm EDT to discover with us the latest features of the Hexoskin platform tailored to enhance your research, projects, and initiatives. Whether you're in healthcare, sports science, human performance, pharmaceutical and biotechnology, academic research or any field where health data plays a crucial role, this webinar is tailored for you.

What to Expect:

• Live demonstrations of the latest Hexoskin platform features.
• Insights into how these features can be applied in your specific field.
• Q&A session with our team to address your questions and needs.

Don't miss out on this opportunity to stay at the forefront of health data technology and leverage the full potential of the Hexoskin platform.

Don't miss out – secure your spot today!

OneView Clinical Research Software Overview

Hexoskin OneView is a clinical software platform that allows health professionals and researchers to design their own protocols and easily monitor their projects and studies.

Our community uses it to collect data from patients in occupational wellness programs, rehabilitation programs, and clinical trials.

Participants can use an app to follow a program's calendar, complete questionnaires and enter all kinds of data you need to track their progress and monitor the performance of your project.

On top of that, you'll find it easy to:

• manage cohorts and calendars
• monitor data quality and compliance
• use study templates, standardized questionnaires and health reports
• easily clone protocols to create new study arms or health programs
• use the sizing tool to pick the right size shirt to onboard participants
• export all data to other systems like Excel, R and SAS for biostatistics
• the tools are available for Astroskin too!

Contact our team to see how we can support your program or study and access a free trial. We offer turnkey services for a wide range of projects, from protocol planning and design, to recruitment and study support, to biostatistics and endpoints. 

Hexoskin @ 2024 JP Morgan Conference

Hexoskin will be in San Francisco again this year during the 42nd Annual J.P. Morgan Healthcare Conference, the largest life sciences investment event in the world.

We'll take the opportunity to meet with our clients and partners who use the Hexoskin software platform and wearables to advance our knowledge of human physiology.

We'll also present our new Hexoskin OneView platform for research and our digital biomarker pipeline in cardiology, respiratory diseases, nervous system disorders, and rare diseases.

Contact us to book a meeting: contact@hexoskin.com

Hexoskin @ HITLAB Innovators Summit 2023

This November at the HITLAB Innovators Summit at Columbia University in NYC we officially launched our new Hexoskin OneView platform for clinical research! For a long time we knew there was a need for better software to support digital biomarker development and clinical research with medical wearables.

We understand the needs of research organizations and clinical sites when it comes to onboarding participants, monitoring compliance and data quality.

So we did something about it.

OneView is the best solution for doing clinical research with Hexoskin and Astroskin wearables. It allows you to:

• Manage cohorts and calendars
• Monitor data quality and compliance
• Use study templates, standardized questionnaires and data reports
• Easily clone studies to create new study arms
• Export all data to other systems like R and SAS for biostatistics

The platform also includes a mobile app for patient reported outcomes and participant tasks management.

On top of that, Hexoskin offers turnkey services for clinical trials: protocol planning and design, recruitment, study support, biostatistics and endpoints, etc.

OneView is already used today by a select group of research organizations and Pharma companies - who joined our beta program earlier this year - to run clinical trials with a decentralized or virtual component. Their feedback has been amazing and has helped us improve OneView to make it an essential research tool.

Please visit our website: hexoskin.com/oneview to learn more about digital tools for clinical research.

The recording from the event is available below:

UNOOSA Webinar on Nov 9th 2023

The UNOOSA (United Nations Office of Outer Space Affairs) has invited Hexoskin's CEO Pierre-Alexandre Fournier to speak about medical research conducted aboard the International Space Station with Astroskin wearable sensors.

The webinar entitled "From Space to Earth: Innovations enabling accessibility on Earth" was live on Thursday November 9th, 2023, you watch a recording of the event here.

There are less than 700 astronauts who have visited space from the time Yuri Gagarin reached orbit for the first time in 1961 to now in 2023. Most of these astronauts were selected to have none or few health conditions.

With space more accessible than ever, we expect thousands of people to visit space in the coming decades on suborbital and orbital flights. Many of these new astronauts who will visit space to work or as travellers will have health conditions or disabilities.

Health research conducted in the space station today  with Astroskin health sensors helps better understand the risks and mitigation strategies to make space more accessible. It also helps better understand the effects of aging on human performance: microgravity has effects on the cardiovascular and musculoskeletal systems analog to accelerated aging.

About the UNOOSA

The United Nations Office for Outer Space Affairs (UNOOSA) works to promote international cooperation in the peaceful use and exploration of space, and in the utilisation of space science and technology for sustainable economic and social development. The Office assists any United Nations Member States to establish legal and regulatory frameworks to govern space activities and strengthens the capacity of developing countries to use space science technology and applications for development by helping to integrate space capabilities into national development programmes.

Astroskin's first suborbital flight with Kellie Gerardi on Virgin Galactic's 05 mission

Kellie Gerardie, a U.S. Payload Specialist and Bioastronautics Researcher for the International Institute for Astronautical Sciences (IIAS), will become this week the first astronaut to use the Astroskin wearable vital signs monitoring system on a suborbital flight.

This is an important milestone for the Astroskin research platform, because the wearable sensors will be worn for the first time during a whole mission: launch, adaptation to microgravity, and landing.

This will allow the IIAS to collect physiological data during critical stages of the spaceflight: from rest to 3g acceleration and then microgravity, an astronaut's body experience stress and needs to adapt to the constant changing environment while the Virgin Galactic's VSS Unity spaceship leaves New Mexico for space and comes back. These changes can be measured using Astroskin's wearable sensors.

The Galactic 05 research mission spaceflight is scheduled to launch on November 2nd 2023 from Spaceport America, 32 km southeast of the city of Trust or Consequences, New Mexico.

The Bio-Monitor Astroskin system is used aboard the International Space Station since 2019 to conduct medical research on the effects of spaceflight on human physiology. Four research projects are currently ongoing, mostly focusing on the cardiovascular and respiratory systems. Its deployment in space has been funded by the Canadian Space Agency and the system has been used by astronauts from CSA, NASA, ESA, JAXA, and the UAE Space Agency.

Over the years, Astroskin has become a standard for complex, continuous vital signs monitoring for space research. The system was awarded the 2022 International Space Station Research Innovation Award for Human Health in Space by the American Astronautical Society.

Kellie Gerardie has been training with the Astroskin to collect baseline data for over a year. The use of Astroskin before, during, and after the flight will be supported the IIAS payload integration team: Yvette Gonzalez, Dr Shawna Pandya, and Dr Aaron Persad.

Read more about Astroskin wearable sensors: https://hexoskin.com/astroskin

Read more about the Galactic 05 mission space research program here.